RemeGen Co., Ltd. (HKG:9995)
69.65
+7.10 (11.35%)
Nov 4, 2026, 2:45 PM HKT
RemeGen Revenue
RemeGen had revenue of 910.49M CNY in the quarter ending September 30, 2026, with 46.41% growth. This brings the company's total for the last twelve months to 8.29B, up 272.34% year-over-year. In the year 2025, RemeGen had annual revenue of 3.25B with 89.36% growth. That makes RemeGen the 6,743rd largest company in the world by revenue and 427th in Hong Kong.
Revenue (ttm)
8.29B CNY
Revenue Growth
+272.34%
P/S Ratio
4.98
Revenue / Employee
2.64M CNY
Employees
3,145
Market Cap
53.76B HKD
Revenue by Geography
- Mainland China 2.28B 70.0%
- USA 974.62M 30.0%
Fiscal year ended Dec 31, 2025 See the full RemeGen breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.25B | 1.53B | 89.36% |
| Dec 31, 2024 | 1.72B | 633.91M | 58.54% |
| Dec 31, 2023 | 1.08B | 310.84M | 40.26% |
| Dec 31, 2022 | 772.11M | -651.79M | -45.78% |
| Dec 31, 2021 | 1.42B | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sino Biopharmaceutical | 38.91B |
| 3SBio | 20.63B |
| Shanghai Henlius Biotech | 8.58B |
| Genscript Biotech | 6.63B |
| Akeso | 3.98B |
| InnoCare Pharma | 3.93B |
| Shanghai Junshi Biosciences | 3.75B |
| Zai Lab | 3.53B |
RemeGen News
- 5 days ago - RemeGen Earnings release: Q3 2026 - Filings
- 5 days ago - RemeGen Slides: Q3 2026 - Filings
- 5 weeks ago - Vor Bio announces new post hoc analysis from Phase 3 trial on telitacicept - TheFly
- 2 months ago - RemeGen Earnings release: Q2 2026 - Filings
- 2 months ago - RemeGen Quarterly report: Q2 2026 - Filings
- 6 months ago - RemeGen Earnings release: Q1 2026 - Filings
- 7 months ago - RemeGen Annual report: Q4 2025 - Filings
- 7 months ago - RemeGen Slides: Q4 2025 - Filings